Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2015 03:00 ET | Source: Hansa Medical AB

Hansa Medical announces prospectus

Important information The information in this press release is not directed at persons located in Australia, Canada, Hong Kong, Japan, New Zealand, the Republic of Korea, Singapore, South Africa,...
October 27, 2015 03:00 ET | Source: Hansa Medical AB

Hansa Medical AB offentliggör prospekt

Viktig information Informationen i detta pressmeddelande riktar sig inte till personer som befinner sig i Australien, Kanada, Hongkong, Japan, Nya Zeeland, Sydkorea, Singapore, Sydafrika, Schweiz, USA...
October 22, 2015 02:00 ET | Source: Hansa Medical AB

Hansa Medicals aktier har godkänts för handel på Nasdaq Stockholm

Viktig information Informationen i detta pressmeddelande riktar sig inte till personer som befinner sig i Australien, Kanada, Hongkong, Japan, Nya Zeeland, Sydkorea, Singapore, Sydafrika, Schweiz, USA...
October 22, 2015 02:00 ET | Source: Hansa Medical AB

Hansa Medical’s shares admitted to trading on Nasdaq Stockholm

Important information The information in this press release is not directed at persons located in Australia, Canada, Hong Kong, Japan, New Zealand, the Republic of Korea, Singapore, South Africa,...
October 13, 2015 02:00 ET | Source: Hansa Medical AB

Hansa Medical applies for stock exchange listing

Important information The information in this press release is not directed at persons located in Australia, Canada, Hong Kong, Japan, New Zealand, the Republic of Korea, Singapore, South Africa,...
October 13, 2015 02:00 ET | Source: Hansa Medical AB

Hansa Medical ansöker om börsnotering

Viktig information Informationen i detta pressmeddelande riktar sig inte till personer som befinner sig i Australien, Kanada, Hongkong, Japan, Nya Zeeland, Sydkorea, Singapore, Sydafrika, Schweiz, USA...
September 15, 2015 02:30 ET | Source: Hansa Medical AB

Data från Hansa Medicals första fas II-studie med IdeS i sensitiserade patienter presenterade på ESOT 2015

Data från Hansa Medicals första avslutade fas II studie med IdeS vid Akademiska sjukhuset i Uppsala har idag har presenterats av studiens ansvariga kliniska prövare, Tomas Lorant, MD, PhD, vid...
September 15, 2015 02:30 ET | Source: Hansa Medical AB

Data from Hansa Medical’s First Phase II study of IdeS in Sensitized Kidney Transplantation Patients Presented in Oral Session at ESOT 2015

Swedish investigators presented data from the first completed phase II study of IdeS in sensitized patients at the 17thCongress of the European Society for Organ Transplantation (ESOT) in Brussels....
September 14, 2015 08:30 ET | Source: Hansa Medical AB

Hansa Medical receives FDA Orphan Drug Designation for IdeS

Hansa Medical today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to IdeS for the prevention of antibody mediated organ rejection in solid organ...
September 14, 2015 08:30 ET | Source: Hansa Medical AB

Hansa Medical beviljas särläkemedelsstatus för IdeS i USA

Hansa Medical meddelar att U.S. Food and Drug Administration (FDA) har beviljat bolagets ansökan om särläkemedelsstatus (Orphan Drug Designation) för läkemedelskandidaten IdeS för prevention av...